Tectonic Therapeutic

Forecast & Rating10 analysts currently cover Tectonic Therapeutic, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $77.56, about 110.6% upside from the current price of $36.83. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 35.2% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Tectonic Therapeutic closely still see room for the stock to rise. Data as of Aug 11, 2026; for reference only and not investment advice.